Public buyer record
This page summarises the contracts and suppliers linked to this buyer in published notices. Values come from those notices.
Totals include values only when they can be added without obvious duplication. Framework totals and inconsistent values stay on their records but are not added here.
| Year | Awards | Value counted | Values not counted |
|---|---|---|---|
| 2026 | 266 | £40,051,946,427 | 36 |
| 2025 | 416 | £5,189,555,145 | 59 |
| 2024 | 727 | £6,187,067,587 | 201 |
| 2023 | 468 | £2,510,813,408 | 94 |
| 2022 | 117 | £401,567,973 | 19 |
| 2021 | 38 | £94,558,170 | 0 |
| 2020 | 6 | £874,185 | 0 |
| 2019 | 3 | £119,301,106 | 0 |
| 2018 | 24 | £1,575,744,961 | 3 |
| 2017 | 21 | £880,085,721 | 1 |
| 2016 | 7 | £1,030,536,650 | 1 |
Suppliers are ordered by published value assigned to one supplier, then by award count. Values shared between suppliers or marked as inconsistent are not assigned.
Page 31 of 35 · 697 awards.
ocds-b5fd17-a7d35837-bb36-4eea-815a-d75471e51b61 / ocds-b5fd17-a7d35837-bb36-4eea-815a-d75471e51b61-1ocds-b5fd17-a7d35837-bb36-4eea-815a-d75471e51b61 / ocds-b5fd17-a7d35837-bb36-4eea-815a-d75471e51b61-2Supplier: PEER POWER YOUTH
ocds-b5fd17-c073c6d4-68da-4b37-b139-f3891812f85e / ocds-b5fd17-c073c6d4-68da-4b37-b139-f3891812f85e-1Supplier: PEER POWER YOUTH
ocds-b5fd17-c073c6d4-68da-4b37-b139-f3891812f85e / ocds-b5fd17-c073c6d4-68da-4b37-b139-f3891812f85e-2ocds-h6vhtk-04e91f / 1ocds-h6vhtk-04e91f / 2ocds-h6vhtk-0517e0 / 2ocds-h6vhtk-059cb9 / 1ocds-h6vhtk-066a57 / 2ocds-h6vhtk-06ec92 / 1Supplier: BBS UK Clinics Ltd
ocds-b5fd17-7677450c-55c6-4991-8fc6-d926dfcf348a / ocds-b5fd17-7677450c-55c6-4991-8fc6-d926dfcf348a-1Supplier: Alstrom Syndrome UK
ocds-b5fd17-1c9eff6a-d319-4444-8340-28925ba3eb8b / ocds-b5fd17-1c9eff6a-d319-4444-8340-28925ba3eb8b-1Supplier: Behcet's Patients Centres
ocds-b5fd17-2d40a28b-9f23-4a02-8b61-dc308a0963db / ocds-b5fd17-2d40a28b-9f23-4a02-8b61-dc308a0963db-1Supplier: Ataxia-Telangiectasia Society
ocds-b5fd17-847f5574-3112-4e55-b357-75c52488b9c6 / ocds-b5fd17-847f5574-3112-4e55-b357-75c52488b9c6-1ocds-b5fd17-cf0bfd2b-5c01-45c3-8b0e-94a9411b34c1 / ocds-b5fd17-cf0bfd2b-5c01-45c3-8b0e-94a9411b34c1-1ocds-b5fd17-59795f49-bfd0-4b85-9ee5-57af48760869 / ocds-b5fd17-59795f49-bfd0-4b85-9ee5-57af48760869-1Supplier: A. Menarini Farmaceutica Internazionale SRL; AMAROX LIMITED; AOP Orphan Limited; Abbvie Ltd; Accord-UK Ltd; Aguettant Ltd; Alan Pharmaceuticals; Alliance Pharmaceuticals Ltd; Amgen Ltd; Aspen Pharmacare UK Limited; Aspire Pharma Ltd; AstraZeneca; Aventis Pharma ltd t/a Sanofi; B. Braun Medical Limited; Bausch + Lomb (Pharma); Bayer Plc; Biofrontera Pharma GmbH; Biovantic Pharma Limited; Brancaster Pharma Ltd; CIPLA (EU) LIMITED; CLINIGEN HEALTHCARE LIMITED; CRESCENT PHARMA LIMITED; CST Pharma Ltd; Cenote Pharma Limited; Chiesi Limited; Colonis Pharma Ltd; DRUGSRUS LIMITED; Day Lewis Medical Ltd; Dexcel Pharma Ltd; Dr Falk Pharma UK Ltd; ELI LILLY & COMPANY LTD; Ennogen Healthcare Ltd; Essential Pharma; Esteve Pharmaceuticals Limited; Evolan Pharma; FONTUS HEALTH LTD; Ferndale Pharmaceuticals Ltd; Ferring Pharmaceuticals Ltd; Flexipharm Austrading Ltd; Flynn Pharma Ltd; Focus Pharmaceuticals Limited; Fresenius Kabi Limited; GLENMARK PHARMACEUTICALS EUROPE LIMITED; GlaxoSmithKline UK Limited; Janssen-Cilag Ltd; Kyowa Kirin Ltd; Lupin Healthcare (UK) Limited; Luye Pharma Ltd; MERCURY PHARMACEUTICALS LIMITED; Martindale Pharma; Merck Serono; Merck Sharpe & Dohme (UK) Limited; Morningside Pharmaeuticals; NECESSITY SUPPLIES LIMITED; NOVARTIS PHARMACEUTICALS UK LIMITED; Napp Pharmaceuticals Ltd; Neon Healthcare; Novo Nordisk; ORPHALAN UK LTD; Organon Pharmaceuticals UK Ltd; PARI; Pfizer Ltd; Pharmacosmos UK Ltd; RPH Pharmaceuticals AB; Reckitt Benckiser; Recordati Rare Diseases UK Ltd; Roche Products Ltd; Rosemont Pharmaceuticals Ltd; SELECTIVE SUPPLIES LIMITED; SERB SA; STIRLING ANGLIAN PHARMACEUTICALS LIMITED; Sandoz Ltd; Simple Pharma; Sun Pharma UK Ltd; THEA PHARMACEUTICALS LIMITED; TILLOMED LABORATORIES LIMITED; Takeda UK Ltd; Tetris Pharma Lts; Teva UK Limited; Thornton and Ross Ltd; Tillotts Pharma UK Ltd; Typharm; Uni Health Distribution Ltd; Univar Solutions; Valneva UK Ltd; Venture Healthcare Ltd; WAYMADE PLC; WOCKHARDT UK LIMITED; Xiromed; ZENTIVA PHARMA UK LIMITED
ocds-b5fd17-44e0652a-0ec7-4c96-8783-61205dae8a30 / ocds-b5fd17-44e0652a-0ec7-4c96-8783-61205dae8a30-1Supplier: ASCEND LABORATORIES (UK) LIMITED; ASTRAZENECA UK LIMITED; Accord UK Ltd; Aspire Pharma Ltd; Aventis Pharma Ltd; C.S.T. Pharma Ltd; CIPLA (EU) LIMITED; CONSILIENT HEALTH (UK) LIMITED; Camurus AB; Day Lewis Medical Ltd; EUMEDICA PHARMA LTD; Essential Pharma; Esteve Pharmaceuticals Limited; Flexipharm Austrading Ltd; Flynn Pharma Ltd; GLENMARK PHARMACEUTICALS EUROPE LIMITED; Grunenthal; Jannsen-Cilag Limited; LOGIXX PHARMA LIMITED; Lupin Healthcare (UK) Limited; MACARTHYS LABORATORIES LIMITED; MEDAC PHARMA LLP; MERCURY PHARMACEUTICALS LIMITED; MORNINGSIDE PHARMACEUTICALS LIMITED; MSN Laboratories Europe Limited; Merck Sharp & Dohme UK Ltd; NAPP PHARMACEUTICALS LIMITED; NOVARTIS PHARMACEUTICALS UK LIMITED; Neuraxpharm UK Ltd; Nordic Pharma Ltd; Norgine Pharmaceuticals Limited; ORPHALAN UK LTD; PFIZER LIMITED; RENASCIENCE PHARMA LIMITED; Rosemont Pharmaceuticals Ltd; SANTEN UK LIMITED; SELECTIVE SUPPLIES LIMITED; SERB LTD; STIRLING ANGLIAN PHARMACEUTICALS LIMITED; SWEDISH ORPHAN BIOVITRUM LTD; SYNCHRONY PHARMA; SYRI LIMITED; Sun Pharma UK Ltd; TAKEDA UK LIMITED; TEVA UK LIMITED; THEA PHARMACEUTICALS LIMITED; THORNTON & ROSS LIMITED; Unicorn Pharmaceuticals Ltd; Viatris UK Healthcare Ltd; ZENTIVA PHARMA UK LIMITED; Zydus Pharmaceuticals UK Ltd
ocds-h6vhtk-05fbbc / 1ocds-h6vhtk-05deb2 / 1ocds-b5fd17-b05f87e8-a814-4dc2-92cd-7fc83ad426e2 / ocds-b5fd17-b05f87e8-a814-4dc2-92cd-7fc83ad426e2-1